Bulk RNA sequencing of splenic cNK cells (CD3-NK1.1+NKp46+) was conducted to uncover the molecular mechanisms by which Prdm1 regulates NK cell anti-tumor immunity (Figure 3A). The gene discussed is NCR1; the disease is neoplasm.